Literature DB >> 30964158

LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.

D Sun1, X-H Fan.   

Abstract

OBJECTIVE: To clarify whether long non-coding RNA (lncRNA) SNHG12 could regulate the proliferative and migratory abilities of ovarian cancer (OC) cells through mediating microRNA-129 (miRNA-129), thus influencing the progression of OC. PATIENTS AND METHODS: The expression patterns of SNHG12 and miRNA-129 in OC tissues and adjacent normal tissues were determined by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Meanwhile, their expression levels in OC cell lines were also examined. Regulatory effects of SNHG12 and miRNA-129 on the proliferative and migratory abilities of OC cells were evaluated by cell counting kit-8 (CCK-8) and transwell assay, respectively. Through the dual-luciferase reporter gene assay, we explored the binding between miRNA-129 with SNHG12 and SOX4. A series of rescue experiments were conducted to clarify the role of SNHG12/miRNA-129/SOX4 regulatory loop in the progression of OC.
RESULTS: SNHG12 was upregulated in OC tissues relative to adjacent normal ones. Patients with metastatic OC or those in stage III-IV had a higher level of SNHG12 compared with non-metastatic or stage I-II patients. The 5-year survival was markedly worse in OC patients with high-level SNHG12 than those in the low-level group. Similarly, SNHG12 was highly expressed in OC cell lines. Overexpression of SNHG12 accelerated A2780 and HO8910 cells to proliferate and migrate. We observed the binding between SNHG12 and miRNA-129, and the latter was lowly expressed in OC. The miRNA-129 overexpression partially reversed the promotive effects of SNHG12 on proliferative and migratory abilities of OC cells. Subsequently, SOX4 was proved to be the target gene of miRNA-129. The SOX4 overexpression was further confirmed to reverse the inhibitory effects of miRNA-129 on proliferative and migratory abilities of OC cells.
CONCLUSIONS: SNHG12 accelerates the proliferative and migratory abilities of OC cells via sponging miRNA-129 to upregulate SOX4.

Entities:  

Year:  2019        PMID: 30964158     DOI: 10.26355/eurrev_201903_17378

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  10 in total

1.  Long non‑coding RNA SNHG12 regulates cell proliferation, invasion and migration in endometrial cancer by targeting miR‑4429.

Authors:  Pengyu Cai; Mingxiu Wu; Bin Zhang; Shuyi Wu; Haiyun Wei; Li Wei
Journal:  Mol Med Rep       Date:  2020-07-28       Impact factor: 2.952

Review 2.  The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use.

Authors:  Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Aida Barreiro-Alonso; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; María Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2020-04-21       Impact factor: 6.639

3.  Prognostic Value of Long Noncoding RNA SNHG12 in Various Carcinomas: A Meta-Analysis.

Authors:  Zhi-Ran Li; Qin Yang; Tao Zhou; Yan-Hua Huang; Hua-Zhu Zhang; Rui Meng; Gong-Hao He
Journal:  Biomed Res Int       Date:  2020-11-26       Impact factor: 3.411

Review 4.  LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.

Authors:  Eleonora A Braga; Marina V Fridman; Alexey A Moscovtsev; Elena A Filippova; Alexey A Dmitriev; Nikolay E Kushlinskii
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

5.  The Long Non-Coding RNA SNHG12 as a Mediator of Carboplatin Resistance in Ovarian Cancer via Epigenetic Mechanisms.

Authors:  Cecilie Abildgaard; Luisa Matos do Canto; Cláudia Aparecida Rainho; Fabio Albuquerque Marchi; Naiade Calanca; Marianne Waldstrøm; Karina Dahl Steffensen; Silvia Regina Rogatto
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

6.  LINC00974 sponges miR-33a to facilitate cell proliferation, invasion, and EMT of ovarian cancer through HMGB2 upregulation.

Authors:  Weiwei Liu; Jing Cheng
Journal:  Genet Mol Biol       Date:  2022-01-31       Impact factor: 1.771

Review 7.  Role of microRNA-129 in cancer and non-cancerous diseases (Review).

Authors:  Bingpeng Deng; Xuan Tang; Yong Wang
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

8.  Prognostic and clinical significance of long non-coding RNA SNHG12 expression in various cancers.

Authors:  Chenghao Zhang; Xiaolei Ren; Wenchao Zhang; Lile He; Lin Qi; Ruiqi Chen; Chao Tu; Zhihong Li
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

Review 9.  SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer.

Authors:  Suraksha Tamang; Varnali Acharya; Deepronil Roy; Rinka Sharma; Apeksha Aryaa; Uttam Sharma; Akanksha Khandelwal; Hridayesh Prakash; Karen M Vasquez; Aklank Jain
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244

10.  Long noncoding RNA SNHG12 is a potential diagnostic and prognostic biomarker in various tumors.

Authors:  Xinzhuang Wang; Qiuyi Jiang; Cheng Zhang; Quan Yang; Lixiang Wang; Jian Zhang; Ligang Wang; Xin Chen; Xu Hou; Dayong Han; Jianing Wu; Shiguang Zhao
Journal:  Chin Neurosurg J       Date:  2021-08-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.